Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SGMOQSANGAMO THERAPEUTICS, INC

OTC · CIK 0001001233
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts399

Identity from submissions API

NameSANGAMO THERAPEUTICS, INC
CIK0001001233
TickersSGMOQ
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN680359556
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone5109706000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • SANGAMO BIOSCIENCES INC (2000-05-19T04:00:00.000Z → 2017-01-06T05:00:00.000Z)
Business address
501 CANAL BLVD.
RICHMOND
CA
94084
CA
Mailing address
501 CANAL BLVD.
RICHMOND
CA
94084
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1616 filing rows loaded from submissions recent; extra archives: CIK0001001233-submissions-001.json (615 filings, 2000-02-11 to 2013-02-03).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005253 005-59049 261558081 34 10550
2026-10-27 8-K 8-K 7.01,9.01 0001193125-26-434171 000-30171 261490325 34 6538556 1 1
2026-10-16 8-K 8-K 7.01,9.01 0001193125-26-423054 000-30171 261463857 34 2105569 1 1
2026-10-07 25-NSE xslF25X02/primary_doc.xml 0001354457-26-000959 000-30171 34 4096
2026-09-21 8-K 8-K 1.03,2.01,9.01 0001193125-26-396644 000-30171 261393830 34 144421 1 1
2026-09-08 8-K FORM 8-K 1.03,2.01,7.01,9.01 0001104659-26-105905 000-30171 261365104 34 4975864 1 1
2026-08-28 8-K 8-K 1.01,1.03,9.01 0001193125-26-374328 000-30171 261339978 34 617664 1 1
2026-08-17 NT 10-Q NT 10-Q 0001193125-26-354282 000-30171 261287561 34 29074
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003615 005-59049 261277302 34 10548
2026-08-13 8-K 8-K 8.01,9.01 0001193125-26-347524 000-30171 261269623 34 176259 1 1
2026-08-12 8-K 8-K 7.01,9.01 0001193125-26-346796 000-30171 261267360 34 3304745 1 1
2026-07-20 8-K 8-K 1.03,3.01 0001193125-26-309012 000-30171 261187259 34 139651 1 1
2026-07-01 8-K 8-K 4.01,8.01,9.01 0001193125-26-292501 000-30171 261145032 34 143159 1 1
2026-06-23 8-K/A 8-K/A 9.01 0001193125-26-279630 000-30171 261111680 34 1087525 1 1
2026-06-23 8-K 8-K 1.01,1.03,2.03,2.05 0001193125-26-278582 000-30171 261109043 34 169100 1 1
2026-05-27 4 xslF345X06/form4-05272026_070509.xml 0002041855-26-000010 5922
2026-05-27 4 xslF345X06/form4-05272026_070507.xml 0002089213-26-000008 5917
2026-05-27 4 xslF345X06/form4-05272026_070505.xml 0001947007-26-000012 5950
2026-05-27 4 xslF345X06/form4-05272026_070504.xml 0001877368-26-000008 5909
2026-05-27 4 xslF345X06/form4-05272026_070501.xml 0001675687-26-000008 5878
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002166 005-59049 26984234 34 10423
2026-05-14 10-Q 10-Q 0001628280-26-035067 000-30171 26978639 34 4442024 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001628280-26-035061 000-30171 26978603 34 301832 1 1
2026-04-30 10-K/A 10-K/A 0001628280-26-028524 000-30171 26919130 34 1071222 1 1
2026-04-29 8-K 8-K 3.01 0001628280-26-028128 000-30171 26910729 34 148384 1 1
2026-04-23 4 xslF345X06/form4-04232026_080406.xml 0002041855-26-000008 5278
2026-04-23 4 xslF345X06/form4-04232026_080436.xml 0001947007-26-000010 5307
2026-04-22 144 xsl144X01/primary_doc.xml 0001950047-26-003686 000-30171 26883624 33 4890
2026-04-06 144 xsl144X01/primary_doc.xml 0001947007-26-000008 000-30171 26839551 33 15463
2026-04-03 4 xslF345X06/form4-04032026_040403.xml 0001947007-26-000006 5945
2026-04-03 4 xslF345X06/form4-04032026_040411.xml 0002089213-26-000006 5912
2026-04-03 4 xslF345X06/form4-04032026_040407.xml 0002041855-26-000006 5917
2026-04-03 4 xslF345X06/form4-04032026_040401.xml 0001675687-26-000006 5872
2026-04-03 4 xslF345X06/form4-04032026_040405.xml 0001877368-26-000006 5904
2026-03-30 10-K 10-K 0001628280-26-022029 000-30171 26813317 34 34833194 1 1
2026-03-30 8-K 8-K 2.02,9.01 0001628280-26-022006 000-30171 26812999 34 326873 1 1
2026-02-26 4 xslF345X05/form4-02262026_090211.xml 0001947007-26-000004 8720
2026-02-26 4 xslF345X05/form4-02262026_090209.xml 0001675687-26-000004 8626
2026-02-26 4 xslF345X05/form4-02262026_090207.xml 0001877368-26-000004 8662
2026-02-26 4 xslF345X05/form4-02262026_090205.xml 0002089213-26-000004 8661
2026-02-26 4 xslF345X05/form4-02262026_090201.xml 0002041855-26-000004 8669
2026-02-04 8-K 8-K 1.01,3.02,9.01 0001193125-26-036792 000-30171 26596122 34 658122 1 1
2026-02-04 424B5 424B5 0001193125-26-036786 333-283179 26596114 33 660218
2026-02-03 8-K 8-K 8.01 0001001233-26-000005 000-30171 26592896 34 6237810 1 1
2026-02-03 FWP FWP 0001193125-26-034556 333-283179 26590307 34 155729
2026-02-03 8-K 8-K 2.02,5.02 0001001233-26-000002 000-30171 26590282 34 146116 1 1
2026-01-26 4 xslF345X05/form4-01262026_090156.xml 0002089213-26-000002 6414
2026-01-26 4 xslF345X05/form4-01262026_090129.xml 0001779092-26-000002 6242
2026-01-26 4 xslF345X05/form4-01262026_090103.xml 0001877368-26-000002 6221
2026-01-26 4 xslF345X05/form4-01262026_090123.xml 0001675687-26-000002 6194
2026-01-26 4 xslF345X05/form4-01262026_090141.xml 0002041855-26-000002 6735
2026-01-26 4 xslF345X05/form4-01262026_090143.xml 0001947007-26-000002 6514
2025-11-26 4 xslF345X05/form4-11262025_091117.xml 0002089213-25-000008 6295
2025-11-26 4 xslF345X05/form4-11262025_091119.xml 0001877368-25-000007 6301
2025-11-26 4 xslF345X05/form4-11262025_091118.xml 0001675687-25-000008 6260
2025-11-26 4 xslF345X05/form4-11262025_091116.xml 0001779092-25-000007 6317
2025-11-26 4 xslF345X05/form4-11262025_091116.xml 0001947007-25-000006 6350
2025-11-26 4 xslF345X05/form4-11262025_091103.xml 0002041855-25-000006 6303
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000814133-25-000099 005-59049 251471821 34 6443
2025-11-06 10-Q 10-Q 0001001233-25-000024 000-30171 251456282 34 6356917 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001001233-25-000023 000-30171 251456274 34 338297 1 1
2025-10-29 8-K 8-K 3.01 0001001233-25-000015 000-30171 251430031 34 149245 1 1
2025-10-24 4 xslF345X05/form4-10242025_051010.xml 0001947007-25-000004 6406
2025-10-24 4 xslF345X05/form4-10242025_051009.xml 0001877368-25-000005 6344
2025-10-24 4 xslF345X05/form4-10242025_051007.xml 0001675687-25-000006 6313
2025-10-24 4 xslF345X05/form4-10242025_051005.xml 0001779092-25-000005 6361
2025-10-24 4 xslF345X05/form4-10242025_051003.xml 0002089213-25-000006 6343
2025-10-24 4 xslF345X05/form4-10242025_051001.xml 0002041855-25-000004 6348
2025-10-09 3 xslF345X02/form3-10092025_101001.xml 0002089213-25-000003 19326
2025-09-30 8-K 8-K 5.02 0001001233-25-000013 000-30171 251360348 34 148192 1 1
2025-09-11 8-K 8-K 5.02 0001001233-25-000011 000-30171 251309192 34 143279 1 1
2025-09-04 8-K 8-K 8.01 0001001233-25-000006 000-30171 251291927 34 6855599 1 1
2025-08-26 4 xslF345X05/form4-08272025_120812.xml 0001415889-25-023081 6319
2025-08-26 4 xslF345X05/form4-08272025_120830.xml 0001415889-25-023079 6358
2025-08-26 4 xslF345X05/form4-08272025_120830.xml 0001415889-25-023077 6370
2025-08-26 4 xslF345X05/form4-08272025_120810.xml 0001415889-25-023074 6353
2025-08-26 4 xslF345X05/form4-08262025_110806.xml 0001415889-25-023071 6390
2025-08-08 S-8 S-8 0001193125-25-177017 333-289433 251198824 33 190259 1 1
2025-08-07 10-Q 10-Q 0001628280-25-038860 000-30171 251193875 34 5573052 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001628280-25-038855 000-30171 251193794 34 328945 1 1
2025-07-24 4 xslF345X05/form4-07242025_080720.xml 0001415889-25-020246 6354
2025-07-24 4 xslF345X05/form4-07242025_080733.xml 0001415889-25-020245 6312
2025-07-24 4 xslF345X05/form4-07242025_080724.xml 0001415889-25-020244 6362
2025-07-24 4 xslF345X05/form4-07242025_080724.xml 0001415889-25-020243 6402
2025-07-24 4 xslF345X05/form4-07242025_080701.xml 0001415889-25-020242 6348
2025-06-24 8-K 8-K 8.01 0001628280-25-032748 000-30171 251066719 34 164505 1 1
2025-06-16 8-K 8-K 5.02,5.07,9.01 0001628280-25-031559 000-30171 251050118 34 724273 1 1
2025-06-16 4 xslF345X05/form4-06162025_040615.xml 0001415889-25-017374 7910
2025-06-16 4 xslF345X05/form4-06162025_040613.xml 0001415889-25-017373 8068
2025-06-16 4 xslF345X05/form4-06162025_040611.xml 0001415889-25-017372 7881
2025-06-16 4 xslF345X05/form4-06162025_040605.xml 0001415889-25-017369 7983
2025-06-16 4 xslF345X05/form4-06162025_040609.xml 0001415889-25-017371 7910
2025-06-16 4 xslF345X05/form4-06162025_040603.xml 0001415889-25-017368 7890
2025-06-16 4 xslF345X05/form4-06162025_040607.xml 0001415889-25-017370 8077
2025-06-16 4 xslF345X05/form4-06162025_040601.xml 0001415889-25-017367 8120
2025-05-28 4 xslF345X05/form4-05282025_040509.xml 0001415889-25-014696 6352
2025-05-28 4 xslF345X05/form4-05282025_040508.xml 0001415889-25-014695 6318
2025-05-28 4 xslF345X05/form4-05282025_040506.xml 0001415889-25-014694 6384
2025-05-28 4 xslF345X05/form4-05282025_040504.xml 0001415889-25-014693 6343
2025-05-28 4 xslF345X05/form4-05282025_040502.xml 0001415889-25-014692 6310
2025-05-13 424B5 424B5 0001140361-25-018702 333-283179 25941465 33 811387
2025-05-13 8-K FORM 8-K 8.01,9.01 0001140361-25-018697 000-30171 25941448 34 729743 1 1
2025-05-13 FWP FWP 0001140361-25-018428 333-283179 25936398 34 671518
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000814133-25-000044 005-59049 25936237 34 6749
2025-05-12 10-Q 10-Q 0001628280-25-024650 000-30171 25934600 34 5195150 1 1
2025-05-06 8-K 8-K 3.01 0001628280-25-022664 000-30171 25917144 34 154242 1 1
2025-04-30 ARS ARS 0001193125-25-104319 000-30171 25889861 34 13333193
2025-04-30 DEF 14A DEF 14A 0001628280-25-020773 000-30171 25889684 34 14247672 1 1
2025-04-24 4 xslF345X05/form4-04242025_080444.xml 0001415889-25-011287 6324
2025-04-24 4 xslF345X05/form4-04242025_080437.xml 0001415889-25-011285 6346
2025-04-24 4 xslF345X05/form4-04242025_080425.xml 0001415889-25-011283 6314
2025-04-24 4 xslF345X05/form4-04242025_080459.xml 0001415889-25-011281 6408
2025-04-24 4 xslF345X05/form4-04242025_080410.xml 0001415889-25-011279 6354
2025-03-17 10-K 10-K 0001628280-25-013088 000-30171 25744382 34 32970119 1 1
2025-03-17 8-K 8-K 2.02,9.01 0001628280-25-013085 000-30171 25744301 34 350799 1 1
2025-02-26 4 xslF345X05/form4-02262025_100209.xml 0001415889-25-005708 14478
2025-02-26 4 xslF345X05/form4-02262025_100233.xml 0001415889-25-005707 14521
2025-02-26 4 xslF345X05/form4-02262025_100200.xml 0001415889-25-005706 14458
2025-02-26 4 xslF345X05/form4-02262025_100216.xml 0001415889-25-005705 14489
2025-02-26 4 xslF345X05/form4-02262025_100229.xml 0001415889-25-005704 14469
2025-02-06 8-K 8-K 8.01 0001628280-25-004197 000-30171 25595536 34 3047737 1 1
2025-01-24 4 xslF345X05/form4-01242025_040112.xml 0001415889-25-002022 6781
2025-01-24 4 xslF345X05/form4-01242025_040107.xml 0001415889-25-002020 6469
2025-01-24 4 xslF345X05/form4-01242025_040110.xml 0001415889-25-002021 6221
2025-01-24 4 xslF345X05/form4-01242025_040104.xml 0001415889-25-002019 6261
2025-01-24 4 xslF345X05/form4-01242025_040101.xml 0001415889-25-002018 6212
2025-01-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000814133-25-000002 005-59049 25516124 34 6673
2024-12-30 8-K 8-K 1.02 0001628280-24-052579 000-30171 241590137 34 160981 1 1
2024-12-10 8-K 8-K 7.01,8.01,9.01 0001628280-24-050545 000-30171 241536929 34 2694034 1 1
2024-11-26 4 xslF345X05/form4-11262024_091117.xml 0001415889-24-027707 9337
2024-11-26 4 xslF345X05/form4-11262024_091107.xml 0001415889-24-027705 9306
2024-11-26 4 xslF345X05/form4-11262024_091141.xml 0001415889-24-027704 9369
2024-11-26 4 xslF345X05/form4-11262024_091108.xml 0001415889-24-027703 9345
2024-11-26 4 xslF345X05/form4-11262024_091121.xml 0001415889-24-027702 9302
2024-11-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-19 17:00:00 9999999995-24-003519 333-283179 241478080 33 1828
2024-11-18 CORRESP filename1.htm 0001140361-24-047186 7041
2024-11-18 UPLOAD filename1.pdf 0000000000-24-012727 333-283179 40111
2024-11-12 S-8 S-8 0001140361-24-046239 333-283180 241450023 33 84343
2024-11-12 S-3 S-3 0001140361-24-046238 333-283179 241450001 33 1466504
2024-11-12 SC 13G/A UnitedStates_13G__SangamoThe.txt 0000932471-24-001167 005-59049 241449441 34 6603
2024-11-12 10-Q 10-Q 0001628280-24-047102 000-30171 241447827 34 7445582 1 1
2024-11-12 8-K 8-K 2.02,9.01 0001628280-24-047099 000-30171 241447752 34 359121 1 1
2024-11-04 SC 13G/A UnitedStates_13G__SangamoThe.txt 0000932471-24-000701 005-59049 241422442 34 5678
2024-10-28 3 xslF345X02/form3-10282024_081047.xml 0001415889-24-025671 18054
2024-10-04 8-K 8-K 7.01 0001628280-24-042308 000-30171 241354899 34 5000303 1 1
2024-08-27 4 xslF345X05/form4-08272024_080842.xml 0001415889-24-022312 9318
2024-08-27 4 xslF345X05/form4-08272024_080808.xml 0001415889-24-022310 9326
2024-08-27 4 xslF345X05/form4-08272024_080835.xml 0001415889-24-022308 9357
2024-08-27 4 xslF345X05/form4-08272024_080803.xml 0001415889-24-022307 9561
2024-08-27 4 xslF345X05/form4-08272024_080830.xml 0001415889-24-022306 9312
2024-08-16 SC 13G/A SC 13G/A 0001193125-24-202234 005-59049 241217890 34 42351
2024-08-15 4 xslF345X05/form4-08152024_080821.xml 0001415889-24-021365 6404
2024-08-06 10-Q 10-Q 0001628280-24-035165 000-30171 241179020 34 5465100 1 1
2024-08-06 8-K 8-K 2.02,9.01 0001628280-24-035160 000-30171 241178976 34 353677 1 1
2024-07-24 8-K 8-K 8.01 0001628280-24-032815 000-30171 241138106 34 287954 1 1
2024-07-08 SC 13G/A us8006771062_070824.txt 0001086364-24-008122 005-59049 241105133 34 12857
2024-06-13 4 xslF345X05/form4-06132024_080609.xml 0001415889-24-016686 6316
2024-06-06 4 xslF345X05/form4-06062024_080627.xml 0001415889-24-015762 7910
2024-06-06 4 xslF345X05/form4-06062024_080652.xml 0001415889-24-015761 8068
2024-06-06 4 xslF345X05/form4-06062024_080624.xml 0001415889-24-015759 7887
2024-06-06 4 xslF345X05/form4-06062024_080652.xml 0001415889-24-015757 7911
2024-06-06 4 xslF345X05/form4-06062024_080623.xml 0001415889-24-015755 8119
2024-06-06 4 xslF345X05/form4-06062024_080652.xml 0001415889-24-015754 7999
2024-06-06 4 xslF345X05/form4-06062024_080627.xml 0001415889-24-015753 7891
2024-06-06 4 xslF345X05/form4-06062024_080600.xml 0001415889-24-015752 8163
2024-06-05 8-K 8-K 5.02,5.03,5.07,9.01 0001628280-24-026903 000-30171 241022930 34 13354380 1 1
2024-05-29 4 xslF345X05/form4-05292024_090558.xml 0001415889-24-014798 9326
2024-05-29 4 xslF345X05/form4-05292024_090552.xml 0001415889-24-014796 9536
2024-05-29 4 xslF345X05/form4-05292024_090511.xml 0001415889-24-014781 9270
2024-05-29 4 xslF345X05/form4-05292024_080536.xml 0001415889-24-014779 9559
2024-05-29 4 xslF345X05/form4-05292024_080518.xml 0001415889-24-014775 9267
2024-05-09 10-Q 10-Q 0001628280-24-022194 000-30171 24930361 34 7093284 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001628280-24-022186 000-30171 24930292 34 329339 1 1
2024-04-30 8-K 8-K 3.01 0001628280-24-019337 000-30171 24897000 34 184404 1 1
2024-04-19 ARS ARS 0001193125-24-102893 000-30171 24857908 34 17961791
2024-04-19 DEF 14A DEF 14A 0001628280-24-016932 000-30171 24857660 34 17475242 1 1
2024-04-05 SC 13G/A sgmo424.txt 0000814133-24-000068 005-59049 24826366 34 4218
2024-04-03 PRE 14A PRE 14A 0001628280-24-014660 000-30171 24820080 34 17459674 1 1
2024-03-25 8-K 8-K 8.01,9.01 0001193125-24-076613 000-30171 24780040 34 915365 1 1
2024-03-25 424B5 424B5 0001193125-24-076462 333-255792 24779150 33 3184490
2024-03-13 8-K 8-K 2.02,9.01 0001628280-24-010790 000-30171 24744604 34 360740 1 1
2024-03-13 10-K 10-K 0001628280-24-010788 000-30171 24744597 34 42319284 1 1
2024-02-27 4 xslF345X05/form4-02272024_100234.xml 0001415889-24-005552 9577
2024-02-27 4 xslF345X05/form4-02272024_100241.xml 0001415889-24-005550 9842
2024-02-27 4 xslF345X05/form4-02272024_100209.xml 0001415889-24-005549 9632
2024-02-27 4 xslF345X05/form4-02272024_100240.xml 0001415889-24-005548 9867
2024-02-27 4 xslF345X05/form4-02272024_100241.xml 0001415889-24-005546 9571
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021891 005-59049 24629439 34 13122
2024-02-12 SC 13G/A SC 13G/A 0001193125-24-032402 005-59049 24622022 34 41032
2024-02-09 SC 13G/A sgmo224.txt 0000814133-24-000014 005-59049 24613463 34 4219
2024-02-06 8-K 8-K 8.01 0001628280-24-003506 000-30171 24600787 34 5485631 1 1
2024-01-26 SC 13G/A us8006771062_012624.txt 0001086364-24-004403 005-59049 24565897 34 13497
2024-01-24 4 xslF345X05/form4-01242024_090142.xml 0001415889-24-001758 6208
2024-01-24 4 xslF345X05/form4-01242024_090106.xml 0001415889-24-001757 6504
2024-01-24 4 xslF345X05/form4-01242024_090116.xml 0001415889-24-001756 6364
2024-01-24 4 xslF345X05/form4-01242024_090133.xml 0001415889-24-001755 6444
2024-01-24 4 xslF345X05/form4-01242024_090135.xml 0001415889-24-001754 6188
2024-01-22 SC 13G/A Sangamo_The_Inc.txt 0000093751-24-000056 005-59049 24547745 34 8552
2024-01-19 8-K 8-K 5.02 0001628280-24-001784 000-30171 24546390 34 191062 1 1
2023-12-13 8-K 8-K 8.01,9.01 0001628280-23-041394 000-30171 231482988 34 2292754 1 1
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056791 6573
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056788 6326
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056786 6329
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056783 6326
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056778 6509
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056777 6408
2023-11-28 4 FORM 4 SUBMISSION 0001209191-23-056774 6335
2023-11-28 3 FORM 3 SUBMISSION 0001209191-23-056770 15375
2023-11-03 8-K 8-K 8.01 0001628280-23-036697 000-30171 231376239 34 1516657 1 1
2023-11-01 10-Q 10-Q 0001628280-23-035989 000-30171 231368484 34 14180890 1 1
2023-11-01 8-K 8-K 2.02,9.01 0001628280-23-035948 000-30171 231368113 34 355842 1 1
2023-10-10 SC 13G/A sgmo1023.txt 0000814133-23-000086 005-59049 231317703 34 4147
2023-09-28 4 FORM 4 SUBMISSION 0000899243-23-019611 6925
2023-08-29 4 FORM 4 SUBMISSION 0001209191-23-047590 6316
2023-08-29 4 FORM 4 SUBMISSION 0001209191-23-047586 6496
2023-08-29 4 FORM 4 SUBMISSION 0001209191-23-047585 6578
2023-08-29 4 FORM 4 SUBMISSION 0001209191-23-047582 6319
2023-08-29 4 FORM 4 SUBMISSION 0001209191-23-047579 6578
2023-08-29 4 FORM 4 SUBMISSION 0001209191-23-047577 6552
2023-08-15 4 FORM 4 SUBMISSION 0001209191-23-045879 6757
2023-08-08 S-8 S-8 0001193125-23-206301 333-273805 231152184 33 73660
2023-08-08 10-Q 10-Q 0001628280-23-028200 000-30171 231151509 34 6150116 1 1
2023-08-08 8-K 8-K 2.02,9.01 0001628280-23-028183 000-30171 231151314 34 340076 1 1
2023-06-26 4 FORM 4 SUBMISSION 0001209191-23-039711 6367
2023-06-13 4 FORM 4 SUBMISSION 0001209191-23-036788 6770
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034407 7940
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034403 8085
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034401 7918
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034396 7939
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034392 8177
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034390 8275
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034389 7922
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034386 8219
2023-06-02 8-K 8-K 5.02,5.03,5.07 0001628280-23-020692 000-30171 23989868 34 13244690 1 1
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032914 6600
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032912 6318
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032910 6440
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032909 6388
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032907 6306
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032906 6606
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032903 6309
2023-05-08 10-Q 10-Q 0001628280-23-016486 000-30171 23898851 34 6357345 1 1
2023-04-26 8-K 8-K 2.02,2.05,5.02,9.01 0001628280-23-013290 000-30171 23850889 34 309452 1 1
2023-04-26 4 FORM 4 SUBMISSION 0001209191-23-025721 6658
2023-04-21 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-045595,2023-04-21 9999999995-23-001002 333-255792 23837805 33 1793
2023-04-17 ARS ARS 0001193125-23-102815 000-30171 23822791 34 42633274
2023-04-17 DEF 14A DEF 14A 0001628280-23-011692 000-30171 23822730 34 20033268 1 1
2023-04-05 PRE 14A PRE 14A 0001628280-23-010849 000-30171 23802410 34 19984063 1 1
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021427 6314
2023-03-17 8-K 8-K 1.02 0001628280-23-008516 000-30171 23743781 34 174980 1 1
2023-03-14 8-K 8-K 8.01 0001628280-23-007777 000-30171 23729397 34 178495 1 1
2023-03-10 8-K 8-K 8.01 0001628280-23-007587 000-30171 23724739 34 179296 1 1
2023-03-07 424B5 424B5 0001193125-23-062112 333-255792 23711048 33 481569
2023-03-07 8-K 8-K 8.01,9.01 0001628280-23-006626 000-30171 23710991 34 732112 1 1
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016399 11452
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016397 11207
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016395 11169
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016393 11025
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016391 10940
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016390 11625
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016387 10943
2023-03-02 8-K 8-K 7.01 0001628280-23-006092 000-30171 23700154 34 181621 1 1
2023-02-23 S-8 S-8 0001193125-23-045598 333-269925 23655855 33 67571
2023-02-23 POS AM POS AM 0001193125-23-045595 333-255792 23655852 33 419957
2023-02-23 10-K 10-K 0001628280-23-004666 000-30171 23655729 34 120305122 1 1
2023-02-22 8-K 8-K 2.02,9.01 0001628280-23-004552 000-30171 23653013 34 358739 1 1
2023-02-22 POSASR POSASR 0001193125-23-044051 333-255792 23650441 33 451674
2023-02-09 SC 13G/A sgmo223.txt 0000814133-23-000038 005-59049 23606535 34 4044
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016900 005-59049 23604206 34 13043
2023-02-07 SC 13G/A Sangamo_Therapeutics_Inc.txt 0000093751-23-000320 005-59049 23594162 34 8507
2023-02-06 4/A FORM 4/A SUBMISSION 0001209191-23-007355 7283
2023-01-24 SC 13G/A us8006771062_012423.txt 0001306550-23-003123 005-59049 23547532 34 13482
2022-12-23 424B5 424B5 0001193125-22-311826 333-255792 221485935 33 498099
2022-12-23 8-K 8-K 1.01,9.01 0001628280-22-032552 000-30171 221485369 34 720319 1 1
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061949 7860
2022-12-19 4 FORM 4 SUBMISSION 0001209191-22-061951 7818
2022-12-19 3 FORM 3 SUBMISSION 0001209191-22-061916 7283
2022-12-19 3 FORM 3 SUBMISSION 0001209191-22-061913 7322
2022-12-19 8-K 8-K 5.02,5.03,9.01 0001628280-22-032209 000-30171 221471165 34 7646384 1 1
2022-12-12 8-K 8-K 8.01 0001628280-22-031695 000-30171 221455886 34 9489761 1 1
2022-11-03 10-Q 10-Q 0001628280-22-028168 000-30171 221357828 34 11997554 1 1
2022-11-03 8-K 8-K 2.02,9.01 0001628280-22-028167 000-30171 221357803 34 344447 1 1
2022-10-12 8-K 8-K 8.01 0001628280-22-026271 000-30171 221305442 34 6780639 1 1
2022-09-22 8-K 8-K 8.01 0001628280-22-025356 000-30171 221259968 34 177161 1 1
2022-09-19 3 FORM 3 SUBMISSION 0001209191-22-050645 16864
2022-08-31 4 FORM 4 SUBMISSION 0000899243-22-030136 9702
2022-08-30 8-K 8-K 8.01 0001628280-22-023857 000-30171 221212845 34 4917591 1 1
2022-08-16 4 FORM 4 SUBMISSION 0001209191-22-046022 6835
2022-08-09 8-K 8-K 5.02 0001628280-22-021955 000-30171 221148608 34 173292 1 1
2022-08-04 10-Q 10-Q 0001628280-22-021140 000-30171 221137577 34 6321922 1 1
2022-08-04 8-K 8-K 2.02,9.01 0001628280-22-021048 000-30171 221136413 34 344813 1 1
2022-06-28 4 FORM 4 SUBMISSION 0001209191-22-039649 6531
2022-06-14 4 FORM 4 SUBMISSION 0001209191-22-036702 6751
2022-06-06 4 FORM 4 SUBMISSION 0001209191-22-034538 5294
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034036 4731
2022-05-25 8-K 8-K 5.02,5.07,9.01 0001628280-22-015378 000-30171 22964199 34 531792 1 1
2022-05-05 10-Q 10-Q 0001628280-22-012629 000-30171 22896157 34 5496098 1 1
2022-05-05 8-K 8-K 2.02,9.01 0001628280-22-012622 000-30171 22896097 34 322478 1 1
2022-05-03 4 FORM 4 SUBMISSION 0001209191-22-026801 6427
2022-04-29 DEFA14A DEFA14A 0001628280-22-011514 000-30171 22875080 34 37129
2022-04-27 4 FORM 4 SUBMISSION 0001209191-22-025811 6256
2022-04-27 4 FORM 4 SUBMISSION 0001209191-22-025809 6618
2022-04-26 4 FORM 4 SUBMISSION 0001209191-22-025671 6508
2022-04-01 DEF 14A DEF 14A 0001628280-22-008159 000-30171 22798303 34 2387968
2022-04-01 8-K 8-K 5.02 0001628280-22-008157 000-30171 22798219 34 173036 1 1
2022-03-29 4 FORM 4 SUBMISSION 0001209191-22-021495 6671
2022-03-28 8-K 8-K 8.01 0001628280-22-007438 000-30171 22775503 34 178817 1 1
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014179 11192
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014176 8272
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014173 11082
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014172 14932
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014170 11416
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014167 10778
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014164 10754
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014161 7808
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014157 7852
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014153 7794
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014149 7997
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014145 8237
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014139 8258
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014134 8395
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014126 7834
2022-02-24 4 FORM 4 SUBMISSION 0001209191-22-012765 9378
2022-02-24 10-K 10-K 0001628280-22-003819 000-30171 22671075 34 52779858 1 1
2022-02-24 8-K 8-K 2.02,9.01 0001628280-22-003812 000-30171 22670837 34 346180 1 1
2022-02-11 SC 13G/A sgmo222.txt 0000814133-22-000043 005-59049 22615574 34 4046
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018509 005-59049 22610780 34 13037
2022-02-09 8-K 8-K 8.01 0001628280-22-002051 000-30171 22603611 34 340562 1 1
2022-02-01 SC 13G/A us8006771062_020122.txt 0000834237-22-004523 005-59049 22579917 34 13506
2022-01-06 8-K 8-K 1.02 0001628280-22-000401 000-30171 22513605 34 181687 1 1
2021-12-30 4 FORM 4 0000875045-21-000061 7492
2021-12-28 4 FORM 4 0000875045-21-000060 9025
2021-12-13 8-K 8-K 8.01 0001628280-21-024895 000-30171 211487094 34 2165079 1 1
2021-12-10 4 FORM 4 0000875045-21-000059 7493
2021-12-09 4 FORM 4 0000875045-21-000058 9586
2021-12-03 4 FORM 4 0000875045-21-000057 9582
2021-11-30 4 FORM 4 0000875045-21-000055 7493
2021-11-22 8-K 8-K 5.02 0001628280-21-023921 000-30171 211429864 34 174816 1 1
2021-11-04 10-Q 10-Q 0001628280-21-021629 000-30171 211378459 34 8135369 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001628280-21-021628 000-30171 211378421 34 344373 1 1
2021-11-03 4 FORM 4 SUBMISSION 0001209191-21-062653 6406
2021-10-22 8-K 8-K 1.01,2.03 0001628280-21-020378 000-30171 211340572 34 178597 1 1
2021-08-17 4 FORM 4 SUBMISSION 0001209191-21-051997 9352
2021-08-09 3 FORM 3 SUBMISSION 0001209191-21-050505 11870
2021-08-05 10-Q 10-Q 0001628280-21-015869 000-30171 211148473 34 7514255 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001628280-21-015847 000-30171 211148213 34 326495 1 1
2021-07-01 8-K 8-K 5.02 0001193125-21-206346 000-30171 211066280 34 139336 1 1
2021-06-29 4 FORM 4 SUBMISSION 0001209191-21-043811 6032
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040405 9560
2021-05-28 8-K 8-K 5.07 0001628280-21-011363 000-30171 21980794 34 201217 1 1
2021-05-27 8-K/A 8-K/A 5.02 0001628280-21-011233 000-30171 21974374 34 180117 1 1
2021-05-05 S-3ASR S-3ASR 0001193125-21-151792 333-255792 21894019 33 1222137
2021-05-04 10-Q 10-Q 0001628280-21-008878 000-30171 21888700 34 11079682 1 1
2021-05-04 8-K 8-K 2.02,9.01 0001628280-21-008871 000-30171 21888498 34 313232 1 1
2021-04-27 4 FORM 4 SUBMISSION 0001209191-21-028745 6310
2021-04-27 4 FORM 4 SUBMISSION 0001209191-21-028744 6397
2021-04-27 4/A FORM 4/A SUBMISSION 0001209191-21-028742 6925
2021-04-27 4/A FORM 4/A SUBMISSION 0001209191-21-028741 11831
2021-04-02 DEF 14A DEF 14A 0001628280-21-006458 000-30171 21802095 34 2485735
2021-03-29 4 FORM 4 SUBMISSION 0001209191-21-023480 6465
2021-03-25 4 FORM 4 SUBMISSION 0001209191-21-023085 13051
2021-03-19 3 FORM 3 SUBMISSION 0001209191-21-022163 12235
2021-03-17 8-K 8-K 5.02 0001628280-21-005022 000-30171 21751411 34 184376 1 1
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015525 11325
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015522 10826
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015520 8499
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015517 10801
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015515 10815
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015514 8460
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015513 8771
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015511 8446
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015510 8648
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015508 8818
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015500 8476
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015499 8582
2021-03-01 4 FORM 4 SUBMISSION 0001209191-21-015497 8486
2021-02-24 10-K 10-K 0001628280-21-003069 000-30171 21673384 34 14923133 1 1
2021-02-24 8-K 8-K 2.02,9.01 0001628280-21-003061 000-30171 21673186 34 334891 1 1
2021-02-16 4 FORM 4 SUBMISSION 0001209191-21-010954 8042
2021-02-11 SC 13G/A sgmo221.txt 0000814133-21-000049 005-59049 21618645 34 4046
2021-02-10 3 FORM 3 SUBMISSION 0001209191-21-009401 6646
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-019033 005-59049 21611890 34 13904
2021-02-04 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000302 005-59049 21589857 34 32901
2021-02-01 SC 13G/A us8006771062_013121.txt 0000834237-21-005567 005-59049 21574591 34 13475
2021-01-28 8-K 8-K 5.02 0001628280-21-000921 000-30171 21561597 34 217093 1 1
2021-01-26 4 FORM 4 SUBMISSION 0001209191-21-005547 6184
2021-01-14 8-K 8-K 8.01,9.01 0001193125-21-008664 000-30171 21527581 34 6323636 1 1
2021-01-06 4 FORM 4 SUBMISSION 0001209191-21-002078 5900
2021-01-06 8-K 8-K 5.02 0001628280-21-000204 000-30171 21510856 34 181180 1 1
2020-12-30 4 FORM 4 SUBMISSION 0001209191-20-065591 6257
2020-12-18 4 FORM 4 SUBMISSION 0001209191-20-064531 9776
2020-12-15 8-K 8-K 5.03,9.01 0001193125-20-318091 000-30171 201389572 34 269457 1 1
2020-12-07 8-K 8-K 7.01,9.01 0001193125-20-311175 000-30171 201371342 34 6373855 1 1
2020-11-30 4 FORM 4 SUBMISSION 0001209191-20-060811 5987
2020-11-04 10-Q 10-Q 0001628280-20-015504 000-30171 201287024 34 8804972 1 1
2020-11-04 8-K 8-K 2.02,9.01 0001628280-20-015492 000-30171 201286701 34 343374 1 1
2020-10-15 S-8 S-8 0001193125-20-269552 333-249482 201240076 33 146146
2020-09-14 8-K 8-K 5.02 0001628280-20-013516 000-30171 201172061 34 193798 1 1
2020-09-11 4 FORM 4 SUBMISSION 0001209191-20-050208 8226
2020-09-11 3 FORM 3 SUBMISSION 0001209191-20-050207 6914

Latest XBRL company facts

One latest value per concept from companyfacts (399 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 414.29M 2026-05-11 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
dei EntityPublicFloat Entity Public Float USD 152.67M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001628280-26-028524
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 17.90M 2020-09-30 2020 Q3 10-Q 2020-11-04 0001628280-20-015504
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 2.45M 2019-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 19.31M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 873,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001001233-25-000024
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 18.34M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 15.08M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 817,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 42.21M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment (Deprecated 2015-01-31) USD 400,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-25 0001564590-15-000950
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.51M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 530.33M 2014-06-30 2014 Q2 10-Q 2014-07-29 0001193125-14-284673
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.64B 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 992,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 25,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003819
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 992,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 583,000 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-07-29 0001193125-14-284673
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 146.50M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap Assets Assets USD 59.97M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AssetsCurrent Assets, Current USD 37.11M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 223.95M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 241,000 2023-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 115.85M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001628280-23-028200
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 170.03M 2016-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022708
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 149,000 2016-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022708
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 36,000 2015-12-31 2016 Q2 10-Q 2016-08-04 0001564590-16-022708
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 169.88M 2016-06-30 2016 Q2 10-Q 2016-08-04 0001564590-16-022708
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 198.82M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 36.70M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028168
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 24.94M 2023-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 219.00M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028168
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 10.86M 2023-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 115.31M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001628280-23-028200
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 76.27M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001628280-23-028200
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 39.04M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001628280-23-028200
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 68.28M 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210364
us-gaap AvailableForSaleSecuritiesGrossRealizedLosses Available-for-sale Securities, Gross Realized Losses USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 25,000 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210364
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 7,000 2011-12-31 2012 FY 10-K 2013-02-26 0001193125-13-076887
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 4.99M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap BusinessAcquisitionSharePrice Business Acquisition, Share Price USD/shares 2.99 2018-10-01 2019 Q2 10-Q 2019-08-07 0001628280-19-010300
us-gaap BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value USD 35.83M 2018-12-31 2019 Q2 10-Q 2019-08-07 0001628280-19-010300
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -1.80M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004163
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 1.65M 2014-06-30 2014 Q2 10-Q 2014-07-29 0001193125-14-284673
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 1.80M 2014-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 55,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 27.59M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 18.99M 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002900
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 27.77M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004163
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 81.00M 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 27.59M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 84.47M 2019-03-31 2019 Q1 10-Q 2019-05-08 0001564590-19-017255
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -19.12M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 6.64M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 41.92M 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.75 2025-09-30 2025 Q3 10-Q 2025-11-06 0001001233-25-000024
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.20M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 960.00M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 350.69M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 350.69M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CommonStockValue Common Stock, Value, Issued USD 4.14M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -32.04M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -254.02M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap ContractualObligation Contractual Obligation USD 10.99M 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003819
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 402,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 5.87M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 897,000 2019-01-01 2020 Q1 10-Q 2020-05-11 0001628280-20-007462
us-gaap CumulativeEffectOnRetainedEarningsNetOfTax1 Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) USD 1.12M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD -568,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD -568,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap CustomerRefundLiabilityCurrent Customer Refund Liability, Current USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003819
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2023-06-30 2023 Q2 10-Q 2023-08-08 0001628280-23-028200
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001628280-23-028200
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss USD 35.56M 2023-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent USD 35.56M 2023-12-31 2024 Q3 10-Q 2024-11-12 0001628280-24-047102
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 35.80M 2023-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-047102
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003069
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 770,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 15,000 2025-03-31 2025 Q1 10-Q 2025-05-12 0001628280-25-024650
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2019-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap DeferredRevenue Deferred Revenue USD -3.56M 2013-12-31 2013 FY 10-K 2014-02-24 0001193125-14-065170
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 35.21M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 23.96M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 1.48M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 130,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 420.55M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 66.76M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 770,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 255.86M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 980.40M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 470.30M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 421,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 17.27M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 62.82M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.33M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 4.75M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 419.78M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 748,000 2014-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill Deferred Tax Liabilities, Goodwill USD 700,000 2013-12-31 2013 FY 10-K 2014-02-24 0001193125-14-065170
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 770,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 6.57M 2019-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2019-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.08 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-23 0001628280-23-004666
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.08 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap DefinedContributionPlanMaximumAnnualContributionPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contribution Per Employee, Amount (Deprecated 2013-01-31) USD 1,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-26 0001193125-13-076887
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount USD 5,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 719,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.08 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.32 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-04 0001628280-21-008878
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.08 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.232 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 302,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-23 0001193125-12-073470
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -766,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations USD 252,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-08 0001564590-19-017255
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3.00M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 18.30M 2015-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap EntityWideRevenueMajorCustomerPercentage Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) pure 1 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-26 0001193125-13-076887
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 71,000 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028636
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -1.80M 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002900
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 1.80M 2014-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002900
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 0.82 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003069
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 700,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 100,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-25 0001564590-15-000950
us-gaap GainLossOnDispositionOfProperty Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) USD 100,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-26 0001193125-13-076887
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001628280-24-047102
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003819
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 6.82M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap Goodwill Goodwill USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-10-28 0001564590-14-004591
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap ImpairmentOfLeasehold Impairment of Leasehold USD 200,000 2024-04-01 2024-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 13.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 100,000 2024-04-01 2024-06-30 2024 Q3 10-Q 2024-11-12 0001628280-24-047102
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -123.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -31.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 469,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeLossIncludingPortionAttributableToNoncontrollingInterest Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax USD -140.13M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028168
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 5.49M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncomeTaxesReceivableNoncurrent Income Taxes Receivable, Noncurrent USD 8.76M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2012-12-31 2012 FY 10-K 2013-02-26 0001193125-13-076887
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncomeTaxExpenseBenefitIntraperiodTaxAllocation Income Tax Expense (Benefit), Intraperiod Tax Allocation USD -5.00M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004163
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 28.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -667,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -25.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 660,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 2.66M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 211,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeTaxReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount USD 177,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 160,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 4.94M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 502,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001001233-25-000024
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -497,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 2.70M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 630,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -4.53M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -449,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 1.33M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-07-29 0001193125-14-284673
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -352,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.20M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap IncreaseDecreaseInPrepaidRent Increase (Decrease) in Prepaid Rent USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-11 0001628280-20-007462
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 320,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-02-25 0001564590-15-000950
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 251,177 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-12 0001628280-25-024650
us-gaap IndefinitelivedIntangibleAssetsAcquired Indefinite-lived Intangible Assets Acquired USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 1.87M 2014-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 1.58M 2015-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap InterestAndOtherIncome Interest and Other Income USD 300,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 403,000 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2.30M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003069
us-gaap LeaseCost Lease, Cost USD 8.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.079 2025-08-25 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 30.65M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.50M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.66M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.20M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 4.42M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 7.50M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 12.38M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.16M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021629
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 3.85M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 1.50M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap Liabilities Liabilities USD 78.92M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 59.97M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap LiabilitiesCurrent Liabilities, Current USD 53.13M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 1.80M 2014-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap MarketableSecurities Marketable Securities USD 120.47M 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002900
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 94.39M 2014-06-30 2014 Q2 10-Q 2014-07-29 0001193125-14-284673
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 42.74M 2014-06-30 2014 Q2 10-Q 2014-07-29 0001193125-14-284673
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003819
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 26.70M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 10.58M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -13,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -11.57M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -19.28M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -18.13M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -31.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -31.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -140.31M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028168
us-gaap NoncontrollingInterestIncreaseFromBusinessCombination Noncontrolling Interest, Increase from Business Combination USD 64,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003819
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 364,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-25 0001564590-15-000950
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OperatingExpenses Operating Expenses USD 33.39M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -31.95M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OperatingLeaseCost Operating Lease, Cost USD 5.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 9.40M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 2.90M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 26.80M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.70M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 19.33M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OperatingLeasePayments Operating Lease, Payments USD 6.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.90M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 158,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 56.42M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 3.67M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 5.65M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 5.61M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 6.04M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 5.95M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 29.50M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.066 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.13M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap OtherAssets Other Assets USD 39,000 2014-06-30 2014 Q2 10-Q 2014-07-29 0001193125-14-284673
us-gaap OtherAssetsCurrent Other Assets, Current USD 183,000 2014-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 870,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -1.05M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 2.85M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD -1.91M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001628280-25-024650
us-gaap OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) USD -35.73M 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-23 0001193125-12-073470
us-gaap OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax USD -7,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001628280-24-022194
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 580,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 651,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015869
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings USD 400,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001564590-17-010305
us-gaap PaymentsForLeasingCosts Payments for Leasing Costs USD 3.50M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001564590-18-004163
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 5.22M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028636
us-gaap PaymentsForRestructuring Payments for Restructuring USD 344,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 379,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap PaymentsToAcquireAdditionalInterestInSubsidiaries Payments to Acquire Additional Interest in Subsidiaries USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003069
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 37.16M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-04 0001193125-13-425338
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001628280-19-013510
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 13,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap PreferredStockValueOutstanding Preferred Stock, Value, Outstanding USD 0 2022-12-31 2022 FY 10-K 2023-02-23 0001628280-23-004666
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.16M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.72M 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023266
us-gaap PrepaidRent Prepaid Rent USD 0 2018-12-31 2019 FY 10-K 2020-02-28 0001628280-20-002582
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-04 0001628280-20-015504
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 23.35M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.73M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments Proceeds from Maturities, Prepayments and Calls of Long-term Investments USD 38.38M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-04 0001193125-13-425338
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 354.59M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0001628280-23-004666
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ProceedsFromSaleOfHeldToMaturitySecurities Proceeds from Sale of Held-to-maturity Securities USD 34.73M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001628280-24-022194
us-gaap ProceedsFromSaleOfInvestmentProjects Proceeds from Sale of Investment Projects USD 10.14M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-24 0001193125-14-065170
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 1.95M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7.58M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-07 0001193125-14-187386
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 344,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -257.83M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 500,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-25 0001564590-15-000950
us-gaap PropertyPlantAndEquipmentFairValueDisclosure Property, Plant, and Equipment, Fair Value Disclosure USD 1.00M 2024-03-31 2024 Q3 10-Q 2024-11-12 0001628280-24-047102
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 53.25M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 10.32M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits Property Subject to or Available for Operating Lease, Number of Units Property 3 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-01 0001628280-23-035989
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned Research and Development Arrangement, Contract to Perform for Others, Compensation Earned USD 20.00M 2014-01-07 2014-01-08 2014 Q3 10-Q 2014-10-28 0001564590-14-004591
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 26.57M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 0 2020-09-30 2020 Q3 10-Q 2020-11-04 0001628280-20-015504
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 0 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 912,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001001233-25-000024
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated employee 110 2023-04-26 2023 Q2 10-Q 2023-08-08 0001628280-23-028200
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.23 2023-04-26 2023 Q2 10-Q 2023-08-08 0001628280-23-028200
us-gaap RestructuringCharges Restructuring Charges USD -552,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap RestructuringReserve Restructuring Reserve USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap RestructuringReserveTranslationAndOtherAdjustment Restructuring Reserve, Translation and Other Adjustment USD 349,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.66B 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 1.44M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 86,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap Revenues Revenues USD 12.64M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012641
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 21.10M 2025-05-12 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 992,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 2.37M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 3.50M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 742,812 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 4.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 5.64M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 4.40M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-24 0001193125-14-065170
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 9.75M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.63 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001628280-25-013088
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 6.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.72 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 15.45M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 4.55 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 69.60M 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 69.62M 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 11.48M 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 10.02 2020-12-31 2020 FY 10-K 2021-02-24 0001628280-21-003069
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.4 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 5.4 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.93 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 9 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 3.70M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 8.73M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap SharePrice Share Price USD/shares 9.54 2019-03-31 2019 Q1 10-Q 2019-05-08 0001564590-19-017255
us-gaap StockDividendsShares Stock Dividends, Shares shares 167,138 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-24 0001193125-14-065170
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -18.95M 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 82.89M 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010788
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.33 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005808
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 900,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 12.65M 2019-04-01 2019-06-30 2020 Q2 10-Q 2020-08-05 0001628280-20-011806
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 1.20M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-18 0001564590-16-012882
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 178,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 344,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 10.36M 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD -379,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001001233-25-000024
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 20.19M 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 2.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 200,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 22,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities USD 2.00M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-24 0001193125-14-065170
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 308,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 600,000 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 52.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap VariableLeaseCost Variable Lease, Cost USD 3.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001628280-26-022029
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 389.62M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 143.11M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-04 0001628280-21-008878
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 389.62M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001628280-26-035067

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →